Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-051838

Principia Biopharma Inc. · PRNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
James Healy
10% Owner
Anand Mehra
10% Owner
Period of report
Sep 18, 2018
Accepted (ET)
Sep 20, 2018 · 7:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510487

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Sep 18, 2018C625,482—A625,482D
Common StockF3,F2Sep 18, 2018C521,235—A1,146,717D
Common StockF4,F2Sep 18, 2018C453,954—A1,600,671D
Common StockF5,F2Sep 18, 2018C167,537—A1,768,208D
Common StockF2Sep 18, 2018P270,000$17.00A2,038,208D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B-1 Preferred StockF1,F2—Sep 18, 2018C625,482D——Common Stock625,4820D
Series B-2 Preferred StockF3,F2—Sep 18, 2018C521,235D——Common Stock521,2350D
Series B-3 Preferred StockF4,F2—Sep 18, 2018C453,954D——Common Stock453,9540D
Series C Preferred StockF5,F2—Sep 18, 2018C167,537D——Common Stock167,5370D
Warrant (Right to Buy)F2,F6,F7,F4—holding————Dec 29, 2022Common Stock20,93820,938D

Explanation of responses